SLIDE PRESENTATION

EX-99.1 2 dex991.htm SLIDE PRESENTATION SLIDE PRESENTATION

Participating:

Albert W. Ondis, Astro-Med Chairman & CEO

Everett V. Pizzuti, Astro-Med President & COO

Joseph P. O’Connell, Astro-Med Vice President & CFO

The Eighth Annual

Needham Growth Conference

January 10-13, 2006

Astro-Med, Inc

Presentation to

Exhibit 99.1

Forward-Looking Statements

Certain of the statements contained in this presentation may be

considered forward-looking statements within the meaning of

Section 27A of the Securities Act of 1933, as amended, and

Section 21E of the Securities Act of 1934, as amended. To the

extent that any of the statements contained herein relating to

Astro-Med, Inc. or its products or markets are forward-looking,

such statements are based on management’s assumptions

and/or current expectations that involve a number of

uncertainties and risks. Such uncertainties and risks include, but

are not limited to, those outlined in our Form 10K and other

public filings, which we make from time to time with the

Securities and Exchange Commission.

Meet

(ALOT)

Meet Astro-Med’s

QuickLabel Systems

Product Group

Product Overview

Label Printers

Printing Supplies

Major QuickLabel Opportunity:

Digital Color Label Printers

Products Requiring Custom Printed Labels

•

Foods and Beverages

•

Cosmetics

•

Nutraceuticals and Pharmaceuticals

•

Chemicals: Agricultural and Cleansers

•

Advertising Novelties

•

Biomedical Devices

•

Tires

Why Companies Buy QuickLabel Printers:

100% Packaging Accuracy, as required by law in

biomedical and pharmaceutical industries. Labels printed

late-stage production on-demand improve accuracy.

Prototype Packaging of products for diverse

domestic and foreign market distribution channels.

Custom Private Labels and Store-Brand Labels to

create higher profit margin opportunities in many retail

and wholesale market segments.

New in FY2007

Photo-Quality

Digital

Label Printer

New

Vivo! Photo-

Quality Label

Printer –

600 dpi

QLS-4100 Xe

Label Printer –

300 dpi

QuickLabel Outlook

•

Current Annual Revenue Rate: $30 million (50%)

•

Fiscal Year 2007:

Significant Growth from

new product sales

Meet Astro-Med’s

Test & Measurement

Product Group

Product Overview

Digital Data Acquisition Systems & Consumables

Specialty Printer Systems & Consumables

Test & Measurement Product

Group

•

Aerospace Systems

•

Power Generation & Transmission

Systems

•

Paper and Metal Mill Systems

•

Automotive Production Systems

Market Applications:

Notable T&M Customers:

The Opportunity in Cockpit Printers

Boeing 787 Dreamliner

Airbus A380

We Are the Exclusive

Supplier of Cockpit

Printers to New

Commercial Aircraft

C-17

C-130

We Are the Exclusive

Supplier of Cockpit

Printers to New

Military Cargo Aircraft

Test & Measurement Outlook

•

Percentage of Current Annual Revenue: 20%

•

Fiscal Year 2007: Continued growth,

propelled by existing contracts

Meet Astro-Med’s

Grass-Telefactor

Product Group

Product Overview

EEG Systems

PSG Systems

System Software

& Supplies

Grass Instruments is the oldest and most

respected name in neurological instrumentation

•

Telefactor is a well-known name in Long Term

Epilepsy Monitoring

Astro-Med acquired both and merged them,

upgrading the resulting product group with proprietary

Astro-Med digital technology

Brand History:

Major Grass-Telefactor Opportunities:

Sleep (PSG):

Rapid growth in treatment of sleep

apnea and other sleep disorders

Long-Term Epilepsy Monitoring:

Product sales to

large Research Hospitals

The Opportunity in Sleep

The Opportunity in Sleep

Neurologists and

pulmonologists

increasingly order

PSG (polysomnograph)

tests on patients with

sleep disorders, often

obese people.

Aura Wireless PSG

Sleep Study System

The Opportunity in Sleep

A Wachovia Securities

study indicates the

potential growth of

sleep studies, finding

that just 22%

of people

who could benefit from

sleep studies have

received them

Aura Wireless PSG

Sleep Study System

Comet EEG System

•

Brain activity before and

after surgery

•

Especially epilepsy

The Opportunity in Long-Term Monitoring

•

Percentage of

Current Annual Revenue: 30%

•

Fiscal Year 2007: Continued growth in Sleep and

Long Term Monitoring

Grass-Telefactor Outlook:

Financials

Astro-Med, Inc.

Operating Results

($ in Millions)

FY 2004 FY 2005 FY 2006*

Sales

$55.8

$56.0

$59.0

Gross Profit

23.0

24.5

41.2%

41.6%

Operating Income

3.6

2.6

3.2

6.5%

4.6%

5.5%

EBITDA

4.9

3.8

4.6

Net Income

$3.2

$2.7

(1)

$2.5

(2)

5.8%

4.8%

4.3%

EPS

$0.60

$0.47

(1)

$0.43

(2)

(1)

Includes tax benefit of $.9 or $0.17 EPS

(2)

Includes tax benefit of $.4 or $0.06 EPS

*Forecast FY2006

Test & Measurement

19% -

$11.5 Million

Grass-Telefactor

30% -

$17.8 Million

QuickLabel Systems

51% -

$29.7 Million

Sales by Product Group

YE January 31*

*Forecast FY2006

Total Sales:

$59.0 Million

QuickLabel Systems

$25.3 $28.4 $29.7

Growth by Product Group

($ in Millions)

YE January 31

FY04

FY05

FY06*

*Forecast

FY2006

Grass-Telefactor

$18.9 $16.5 $17.8

Test & Measurement

$11.6 $11.1 $11.5

Totals

$55.8 $56.0 $59.0

Cash Equivalents and Marketable Securities

$13.8

Balance Sheet

($ in Millions)

A/O 10/29/05

Working Capital

(excluding cash, cash equivalents, and marketable securities)

$16.7

Total Assets

$48.0

Total Debt, including current portion

-$0-

Total Stockholders’

Equity

$39.5

Total Shares Outstanding

5,313,000

Market Capitalization

$62 Million

52 Week Range

$8.25 -

$13.19

Management Insider Ownership

33%

Institutional Ownership

23%

Dividend Paid

56 Consecutive Quarters

Years of Profitable Operations

26/28 Years

Investment Considerations

(NASDAQ: ALOT)

A/O 12/31/05

P/E Ratio*

31x

P/B Ratio*

1.6

Book Value per Share**

$7.44

Cash per Share**

$2.59

Dividend Yield

1.5%

*A/O 12/31/05

**A/O 10/29/05

Investment Considerations

(NASDAQ: ALOT)

Stock Performance

3-Year Monthly Comparison

As of 12/31/05

Investment Considerations

(NASDAQ: ALOT)

Positioned for Growth & Profitability

Proprietary Technology

Strong Capital Structure

Multiple Million-Dollar Markets

New Products Pipeline to support growth

Experienced Management with a proven track record

Established Global Distribution

Thank You

ALOT !

Visit

at: